News
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. Shares of independent fintech company Supply@Me (LSE:SYME) are in the red today, closing at 0.1560p as January 6th (17:59 GMT). SYME shares have continued to decline in value as the market gives the… Continue reading Supply@Me Capital Share Forecast January 2022 – Time to Buy SYME?
GBP/USD is trading slightly bearish at $1.3630 ahead of US inflation figures. The day before, GBP/USD closed at $1.3635 after hitting a high of $1.3637 and a low of $1.3561.
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. Shares of American video game holding company Take-Two Interactive (NASDAQ: TTWO) are in the green today, after closing at $148.42 as of January 11th (19:59 EST). Various reports indicated that Take-Two Interactive is… Continue reading Take-Two Interactive Share Forecast January 2022 – Time to Buy TTWO?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. While the broader markets have been weak in 2022 amid rate hike fears, bank stocks have outperformed. The sector had outperformed the markets last year as well. Banks generally borrow at the short… Continue reading 5 Best Bank Stocks to Buy in January 2022
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. The price of Rivian stock is down 21% so far this month after multiple news seem to have unleashed another wave of negative momentum for the electric vehicle startup. On 5 January, a… Continue reading Rivian Stock Down 21% in January – Time to Buy RIVN Stock?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. Pfizer (NYSE: PFE) stock is trading with a YTD loss this year after the strong outperformance in 2021. The stock is now down almost 9% from the 52-week highs. However, its drawdown from… Continue reading Pfizer Stock Price Forecast January 2022 – Time to Buy PFE Stock?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. ChainScore brings multi-chain credit data to de-risk DeFi on NEAR protocol, providing more use cases for the blockchain and motivating investors to buy NEAR Crypto market down by 0.89% over the last day… Continue reading NEAR Protocol Price Up by 16% – Time to Buy NEAR?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. The price of Palantir stock has kept declining in January following the weakness that started back in November when the company reported its financial results covering the third quarter of the 2021 fiscal… Continue reading Palantir Stock Down 9% in January – Time to Buy PLTR Stock?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. Oasis Network trades in the green despite the bears engulfing the crypto market, prompting investors to buy ROSE The year 2022 begins on a stellar note for Oasis Network after recording impressive gains… Continue reading Oasis Network Price Up By 13% – Time To Buy ROSE Coin?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. Shares of molecular diagnostics company Genedrive(LSE: GDR) are in the red today, currently trading at 31p at the time of writing. Genedrive shares have surged over 230% in the last month. Genedrive –… Continue reading Genedrive Share Forecast January 2022 – Time to Buy GDR?
